SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 238 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,011 | +5.9% | 140,329 | 0.0% | 0.23% | +12.1% |
| Q2 2023 | $16,070 | -16.9% | 140,329 | 0.0% | 0.21% | -21.9% |
| Q1 2023 | $19,342 | +24.1% | 140,329 | +16.6% | 0.26% | +28.0% |
| Q4 2022 | $15,592 | -99.9% | 120,329 | 0.0% | 0.21% | +13.1% |
| Q3 2022 | $13,301,000 | +47.5% | 120,329 | 0.0% | 0.18% | +61.9% |
| Q2 2022 | $9,020,000 | -4.0% | 120,329 | 0.0% | 0.11% | +10.8% |
| Q1 2022 | $9,400,000 | -13.3% | 120,329 | 0.0% | 0.10% | 0.0% |
| Q4 2021 | $10,836,000 | -2.6% | 120,329 | 0.0% | 0.10% | -10.5% |
| Q3 2021 | $11,128,000 | +19.0% | 120,329 | 0.0% | 0.11% | +18.8% |
| Q2 2021 | $9,354,000 | +4.3% | 120,329 | 0.0% | 0.10% | +9.1% |
| Q1 2021 | $8,968,000 | -56.3% | 120,329 | 0.0% | 0.09% | -57.3% |
| Q4 2020 | $20,515,000 | +0.5% | 120,329 | -17.2% | 0.21% | -10.4% |
| Q3 2020 | $20,409,000 | -12.4% | 145,329 | 0.0% | 0.23% | -15.4% |
| Q2 2020 | $23,302,000 | +63.9% | 145,329 | 0.0% | 0.27% | +37.4% |
| Q1 2020 | $14,216,000 | -24.2% | 145,329 | 0.0% | 0.20% | -11.6% |
| Q4 2019 | $18,753,000 | +71.3% | 145,329 | 0.0% | 0.22% | +61.2% |
| Q3 2019 | $10,946,000 | -37.5% | 145,329 | +26.0% | 0.14% | -36.2% |
| Q2 2019 | $17,524,000 | +480.5% | 115,329 | +355.3% | 0.22% | +473.7% |
| Q1 2019 | $3,019,000 | -20.9% | 25,329 | -27.6% | 0.04% | -30.9% |
| Q4 2018 | $3,816,000 | -49.8% | 34,968 | -25.7% | 0.06% | -43.9% |
| Q3 2018 | $7,598,000 | -17.2% | 47,046 | -32.2% | 0.10% | -22.8% |
| Q2 2018 | $9,177,000 | +84.1% | 69,427 | +3.2% | 0.13% | +64.9% |
| Q1 2018 | $4,984,000 | -10.9% | 67,272 | -33.0% | 0.08% | -4.9% |
| Q4 2017 | $5,591,000 | +0.6% | 100,478 | -18.0% | 0.08% | +2.5% |
| Q3 2017 | $5,555,000 | +35.6% | 122,469 | +0.8% | 0.08% | +27.4% |
| Q2 2017 | $4,097,000 | +67.3% | 121,528 | +46.9% | 0.06% | +51.2% |
| Q1 2017 | $2,449,000 | +2591.2% | 82,735 | +2404.1% | 0.04% | +1950.0% |
| Q4 2016 | $91,000 | – | 3,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |